Cargando…

Chronic Stress Exposure Reduces Parvalbumin Expression in the Rat Hippocampus through an Imbalance of Redox Mechanisms: Restorative Effect of the Antipsychotic Lurasidone

BACKGROUND: Psychiatric disorders are associated with altered function of inhibitory neurotransmission within the limbic system, which may be due to the vulnerability of selective neuronal subtypes to challenging environmental conditions, such as stress. In this context, parvalbumin-positive GABAerg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rossetti, Andrea C, Paladini, Maria Serena, Colombo, Martina, Gruca, Piotr, Lason-Tyburkiewicz, Magdalena, Tota-Glowczyk, Katarzyna, Papp, Mariusz, Riva, Marco A, Molteni, Raffaella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Regular Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119300/ https://www.ncbi.nlm.nih.gov/pubmed/29788232 http://dx.doi.org/10.1093/ijnp/pyy046

Ejemplares similares

T221. LURASIDONE DISPLAYS ANTIDEPRESSANT AND PRO-COGNITIVE EFFECTS IN THE CHRONIC MILD STRESS MODEL: A ROLE FOR REDOX MECHANISMS AND PARVALBUMIN EXPRESSION
por: Rossetti, Andrea Carlo, et al.
Publicado: (2018)

Dopaminergic mechanisms in memory consolidation and antidepressant reversal of a chronic mild stress-induced cognitive impairment`
por: Papp, Mariusz, et al.
Publicado: (2017)

Antidepressant, anxiolytic and procognitive effects of rivastigmine and donepezil in the chronic mild stress model in rats
por: Papp, Mariusz, et al.
Publicado: (2016)

The antipsychotic-like effects of the mGlu group III orthosteric agonist, LSP1-2111, involves 5-HT(1A) signalling
por: Wierońska, Joanna M., et al.
Publicado: (2013)

Involvement of GABA(B) Receptor Signaling in Antipsychotic-like Action of the Novel Orthosteric Agonist of the mGlu(4) Receptor, LSP4-2022
por: Woźniak, Monika, et al.
Publicado: (2016)

Lurasidone Exerts Antidepressant Properties in the Chronic Mild Stress Model through the Regulation of Synaptic and Neuroplastic Mechanisms in the Rat Prefrontal Cortex
por: Luoni, Alessia, et al.
Publicado: (2015)

Altered responsiveness of the antioxidant system in chronically stressed animals: modulation by chronic lurasidone treatment
por: Spero, Vittoria, et al.
Publicado: (2022)

Stress Modifies the Expression of Glucocorticoid-Responsive Genes by Acting at Epigenetic Levels in the Rat Prefrontal Cortex: Modulatory Activity of Lurasidone
por: Brivio, Paola, et al.
Publicado: (2021)

The antipsychotic-like effects in rodents of the positive allosteric modulator Lu AF21934 involve 5-HT(1A) receptor signaling: mechanistic studies
por: Wierońska, Joanna M., et al.
Publicado: (2014)

Insufficiency of ventral hippocampus to medial prefrontal cortex transmission explains antidepressant non-response
por: Papp, Mariusz, et al.
Publicado: (2021)

Antipsychotic treatments; focus on lurasidone
por: Sumiyoshi, Tomiki
Publicado: (2013)

Resilience to chronic mild stress-induced anhedonia preserves the ability of the ventral hippocampus to respond to an acute challenge
por: Brivio, Paola, et al.
Publicado: (2022)

Early effects of lurasidone treatment in a chronic mild stress model in male rats
por: Creutzberg, Kerstin Camile, et al.
Publicado: (2023)

Neutropenia with Multiple Antipsychotics Including Dose Dependent Neutropenia with Lurasidone
por: Sood, Shabnam
Publicado: (2017)

Lurasidone: a novel antipsychotic agent for the treatment of schizophrenia and bipolar depression
por: Loebel, Antony, et al.
Publicado: (2015)

Involvement of the IL-6 Signaling Pathway in the Anti-Anhedonic Effect of the Antidepressant Agomelatine in the Chronic Mild Stress Model of Depression
por: Rossetti, Andrea C., et al.
Publicado: (2022)

Mild Decrease in Blood Glucose Levels May Predict Efficacy of Antipsychotic Lurasidone
por: Nagamine, Takahiko, et al.
Publicado: (2023)

AMPA receptors mediate the pro-cognitive effects of electrical and optogenetic stimulation of the medial prefrontal cortex in antidepressant non-responsive Wistar–Kyoto rats
por: Papp, Mariusz, et al.
Publicado: (2020)

The 5-HT(1A) receptor biased agonists, NLX-204 and NLX-101, display ketamine-like RAAD and anti-TRD activities in rat CMS models
por: Papp, Mariusz, et al.
Publicado: (2023)

Identification of clinical phenotypes in schizophrenia: the role of lurasidone
por: Riva, Marco Andrea, et al.
Publicado: (2021)

Transcriptional and morphological profiling of parvalbumin interneuron subpopulations in the mouse hippocampus
por: Que, Lin, et al.
Publicado: (2021)

An Evaluation of the Effects of the Novel Antipsychotic Drug Lurasidone on Glucose Tolerance and Insulin Resistance: A Comparison with Olanzapine
por: Wu, Claire, et al.
Publicado: (2014)

Redox Imbalance and Stroke
por: Ye, Ruidong, et al.
Publicado: (2016)

Lurasidone hydrochloride
por: Zhang, Hua, et al.
Publicado: (2012)

Chronic N-Acetyl-Cysteine Treatment Enhances the Expression of the Immediate Early Gene Nr4a1 in Response to an Acute Challenge in Male Rats: Comparison with the Antidepressant Venlafaxine
por: Brivio, Paola, et al.
Publicado: (2023)

Differential Neuroinflammatory Response in Male and Female Mice: A Role for BDNF
por: Rossetti, Andrea Carlo, et al.
Publicado: (2019)

Chronic Mild Stress and Venlafaxine Treatment Were Associated with Altered Expression Level and Methylation Status of New Candidate Inflammatory Genes in PBMCs and Brain Structures of Wistar Rats
por: Bialek, Katarzyna, et al.
Publicado: (2021)

Cholinergic imbalance in the multiple sclerosis hippocampus
por: Kooi, Evert-Jan, et al.
Publicado: (2011)

Loss of Parvalbumin in the Hippocampus of MAM Schizophrenia Model Rats Is Attenuated by Peripubertal Diazepam
por: Du, Yijuan, et al.
Publicado: (2016)

Lurasidone-induced Oculogyric Crisis
por: Das, Soumitra, et al.
Publicado: (2017)

Lurasidone-induced Parkinsonism and Hyperprolactinemia
por: Suthar, Navratan, et al.
Publicado: (2019)

Lurasidone in treatment of manic episode
por: Sánchez-Rivero, I.
Publicado: (2022)

The effects of agomelatine and imipramine on liver cytochrome P450 during chronic mild stress (CMS) in the rat
por: Haduch, Anna, et al.
Publicado: (2020)

Lurasidone compared to other atypical antipsychotic monotherapies for adolescent schizophrenia: a systematic literature review and network meta-analysis
por: Arango, Celso, et al.
Publicado: (2019)

Impact of Lurasidone and Other Antipsychotics on Body Weight: Real-World, Retrospective, Comparative Study of 15,323 Adults with Schizophrenia
por: Pochiero, Ilena, et al.
Publicado: (2021)

Effectiveness of lurasidone in schizophrenia or schizoaffective patients switched from other antipsychotics: a 6-month, open-label, extension study
por: Citrome, Leslie, et al.
Publicado: (2013)

Short-term efficacy and safety of lurasidone versus placebo in antipsychotic-naïve versus previously treated adolescents with an acute exacerbation of schizophrenia
por: Correll, Christoph U., et al.
Publicado: (2022)

Redox Imbalance in the Development of Colorectal Cancer
por: Liu, Hao, et al.
Publicado: (2017)

Ferroptosis: Redox Imbalance and Hematological Tumorigenesis
por: Lan, Hongying, et al.
Publicado: (2022)

Redox Imbalance in Chronic Inflammatory Diseases
por: Li, Ziqing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qgh6ulifitfmui3njhq64r75dp